PDF《聯邦制药国际控股有限公司》

30 June 2010, the Group has a total of

174 products qualified to produce in the PRC and/or Hong Kong based on the Drug Registration Approvals in the PRC and Certificates of Drug or Product Registration in Hong Kong.

76 were in production, and

34 were listed in Insurance Catalogue.

12 finished products are in the list of the Nation's Essential Drugs List. The group is currently a component of the Hang Seng Composite Index Series. For more information about TUL, please visit the company's website at www.tul.com.hk. Issued by Creativeline Communications for and on behalf of C The United Laboratories International Holdings Limited. For further information, please contact: Creativeline Communications Mr. Wayne Chau / Ms. Sylvia Lau Tel: (852)

2730 6212/

6390 9406 Fax: (852)

27360745 EmailU [email protected] / [email protected]